NKTR
$39.22+7.04%
Nektar TherapeuticsStock · HealthcareRussell 2000 · 0.08% of IWMNasdaq Composite · 0.004% of ONEQUS Stock Market · 0.003% of VTIRussell 3000 · 0.003% of IWV
Nektar Therapeutics total returns by year (including dividends)
As of market close, Oct 20, 2026
Nektar Therapeutics total returns by year (1995–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $42.28 | $39.22 | 0.0% | -7.2% | |
| 2025 | $13.95 | $42.28 | 0.0% | +203.1% | |
| 2024 | $8.40 | $13.95 | 0.0% | +66.1% | |
| 2023 | $33.90 | $8.40 | 0.0% | -75.2% | |
| 2022 | $202.65 | $33.90 | 0.0% | -83.3% | |
| 2021 | $255.00 | $202.65 | 0.0% | -20.5% | |
| 2020 | $323.85 | $255.00 | 0.0% | -21.3% | |
| 2019 | $493.05 | $323.85 | 0.0% | -34.3% | |
| 2018 | $895.80 | $493.05 | 0.0% | -45.0% | |
| 2017 | $184.05 | $895.80 | 0.0% | +386.7% | |
| 2016 | $252.75 | $184.05 | 0.0% | -27.2% | |
| 2015 | $232.50 | $252.75 | 0.0% | +8.7% | |
| 2014 | $170.25 | $232.50 | 0.0% | +36.6% | |
| 2013 | $111.15 | $170.25 | 0.0% | +53.2% | |
| 2012 | $84.00 | $111.15 | 0.0% | +32.3% | |
| 2011 | $192.75 | $84.00 | 0.0% | -56.4% | |
| 2010 | $139.80 | $192.75 | 0.0% | +37.9% | |
| 2009 | $83.40 | $139.80 | 0.0% | +67.6% | |
| 2008 | $100.65 | $83.40 | 0.0% | -17.1% | |
| 2007 | $228.15 | $100.65 | 0.0% | -55.9% | |
| 2006 | $246.90 | $228.15 | 0.0% | -7.6% | |
| 2005 | $303.60 | $246.90 | 0.0% | -18.7% | |
| 2004 | $204.15 | $303.60 | 0.0% | +48.7% | |
| 2003 | $121.20 | $204.15 | 0.0% | +68.4% | |
| 2002 | $278.25 | $121.20 | 0.0% | -56.4% | |
| 2001 | $757.50 | $278.25 | 0.0% | -63.3% | |
| 2000 | $319.22 | $757.50 | 0.0% | +137.3% | |
| 1999 | $247.50 | $319.22 | 0.0% | +29.0% | |
| 1998 | $195.00 | $247.50 | 0.0% | +26.9% | |
| 1997 | $113.44 | $195.00 | 0.0% | +71.9% | |
| 1996 | $73.13 | $113.44 | 0.0% | +55.1% | |
| 1995 | $69.38 | $73.13 | 0.0% | +5.4% |
- Annualized
- -1.1%
- 1995–2026
- Average year
- +24.3%
- 31 full years
- Best year
- +386.7%
- 2017
- Worst year
- -83.3%
- 2022
- Positive years
- 17/31
- 55% up
Annualized (CAGR)
-1.1%
1995–2026
Average year
+24.3%
31 full years
Best year
+386.7%
2017
Worst year
-83.3%
2022
Positive years
17/31
55% up
Total return by period#
Annual
-200%0%200%
1995+5.4%'95
1996+55%
1997+72%
1998+27%'98
1999+29%
2000+137%
2001-63%'01
2002-56%
2003+68%
2004+49%'04
2005-19%
2006-7.6%
2007-56%'07
2008-17%
2009+68%
2010+38%'10
2011-56%
2012+32%
2013+53%'13
2014+37%
2015+8.7%
2016-27%'16
2017+387%
2018-45%
2019-34%'19
2020-21%
2021-21%
2022-83%'22
2023-75%
2024+66%
2025+203%'25
2026-7.2%
Methodology#
Total returns, dividends reinvested, measured on NKTR. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Nektar Therapeutics's average annual return?
- Since 1995, Nektar Therapeutics (NKTR) has returned about -1.1% a year (the compound annual growth rate) and an average calendar-year return of 24.3%.
- What were Nektar Therapeutics's best and worst years?
- Over 1995–2026, the best year was 2017 (+386.7%) and the worst was 2022 (-83.3%).
- How often is Nektar Therapeutics up in a year?
- 17 of the 31 full years since 1995 were positive — about 55% of the time.
More on Nektar Therapeutics
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100